Pulsatile drug-delivery systems
- PMID: 11763497
Pulsatile drug-delivery systems
Abstract
Delivery systems with a pulsatile-release pattern are receiving increasing interest for the development of drugs for which conventional controlled drug-release systems with a continuous release are not ideal. These drugs often have a high first-pass effect or special chronopharmacological needs. A pulsatile-release profile is characterized by a time period of no release (lag time) followed by a rapid and complete drug release. Pulsatile drug-delivery systems can be classified into site-specific systems in which the drug is released at the desired site within the intestinal tract (e.g., the colon), or time-controlled devices in which the drug is released after a well-defined time period. Site-controlled release is usually controlled by environmental factors, like the pH or enzymes present in the intestinal tract, whereas the drug release from time-controlled systems is controlled primarily by the delivery system and, ideally, not by the environment. This review covers various single- and multiple-unit oral pulsatile drug-delivery systems with an emphasis on time-controlled drug-release systems.
Similar articles
-
Pharmaceutical approaches to colon targeted drug delivery systems.J Pharm Pharm Sci. 2003 Jan-Apr;6(1):33-66. J Pharm Pharm Sci. 2003. PMID: 12753729 Review.
-
Oral pulsatile drug delivery systems.Expert Opin Drug Deliv. 2005 Sep;2(5):855-71. doi: 10.1517/17425247.2.5.855. Expert Opin Drug Deliv. 2005. PMID: 16296783 Review.
-
Predictable pulsatile release of tramadol hydrochloride for chronotherapeutics of arthritis.Drug Deliv. 2010 Jul;17(5):273-81. doi: 10.3109/10717541003706240. Drug Deliv. 2010. PMID: 20524906
-
Oral pulsatile delivery: rationale and chronopharmaceutical formulations.Int J Pharm. 2010 Oct 15;398(1-2):1-8. doi: 10.1016/j.ijpharm.2010.07.026. Epub 2010 Jul 23. Int J Pharm. 2010. PMID: 20655998 Review.
-
Design and in vitro evaluation of formulations with pH and transit time controlled sigmoidal release profile for colon-specific delivery.Drug Deliv. 2009 Aug;16(6):295-303. doi: 10.1080/10717540902989936. Drug Deliv. 2009. PMID: 19606943
Cited by
-
Interchangeability, Safety and Efficacy of Modified-Release Drug Formulations in the USA: The Case of Opioid and Other Nervous System Drugs.Clin Drug Investig. 2016 Apr;36(4):281-92. doi: 10.1007/s40261-015-0374-7. Clin Drug Investig. 2016. PMID: 26818406
-
Chrono-tailored drug delivery systems: recent advances and future directions.Drug Deliv Transl Res. 2024 Jul;14(7):1756-1775. doi: 10.1007/s13346-024-01539-4. Epub 2024 Feb 28. Drug Deliv Transl Res. 2024. PMID: 38416386 Free PMC article. Review.
-
Colon targeted drug delivery systems: a review on primary and novel approaches.Oman Med J. 2010 Apr;25(2):79-87. doi: 10.5001/omj.2010.24. Oman Med J. 2010. PMID: 22125706 Free PMC article.
-
Pulsatile protein release from monodisperse liquid-core microcapsules of controllable shell thickness.Pharm Res. 2014 Nov;31(11):3201-10. doi: 10.1007/s11095-014-1412-5. Epub 2014 May 16. Pharm Res. 2014. PMID: 24831313 Free PMC article.
-
Chronomodulated drug delivery system of urapidil for the treatment of hypertension.Int J Pharm Investig. 2015 Apr-Jun;5(2):107-13. doi: 10.4103/2230-973X.153389. Int J Pharm Investig. 2015. PMID: 25838996 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources